INTREPId (INTermediate Risk Erection PreservatIon Trial)
Public ClinicalTrials.gov record NCT04025372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Trial of Radiation Therapy and Darolutamide for Prostate Cancer
Study identification
- NCT ID
- NCT04025372
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Enrollment
- 234 participants
Conditions and interventions
Conditions
Interventions
- Bicalutamide Drug
- GnRH Agonist Drug
- Radiation Therapy Radiation
- Darolutamide Drug
Drug · Radiation
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2020
- Primary completion
- Sep 30, 2027
- Completion
- Feb 29, 2028
- Last update posted
- Dec 14, 2025
2020 – 2028
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stamford Hospital | Stamford | Connecticut | 06904 | — |
| Beth Israel Deaconness Medical Center | Boston | Massachusetts | 02115 | — |
| Brigham and Women Hospital | Boston | Massachusetts | 02115 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center | Milford | Massachusetts | 01757 | — |
| Dana-Farber/Brigham and Women's Cancer Center in Clinical Affiliation with South Shore Hospital | South Weymouth | Massachusetts | 02190 | — |
| Washington University School of Medicine in St. Louis | St Louis | Missouri | 63108 | — |
| XCancer Omaha / Urology Cancer Center | Omaha | Nebraska | 68130 | — |
| NYU Long Island | Garden City | New York | 11530 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| Associated Medical Professionals of NY | Syracuse | New York | 13210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04025372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04025372 live on ClinicalTrials.gov.